DEVELOP AN INNOVATIVE APPROACH TO TREATMENT OF RARE CANCER CANCER (HODGKIN’S LYMPHOMA, HODGKIN’S LYMPHOMA, SKIN CARCINOMA, MSI CANCER, CANCER OF KIDNEY CANCER, KIDNEY CANCER, THYROID CANCER, DEFICIENCY OF THE PIERUATE DEHYDROGENASE, MEDIOR1) CHARACTERISATION OF CELL MODELS AND BIOLOGICAL SAMPLES USING A GENOMIC APPROACH BASED ON THE PHENOTYPE OF RARE CANCER MODELS OF RARE CANCERS CAPABLE OF OBTAINING ESSENTIAL INFORMATION ABOUT THE GENOME, THE EXOMA, THE TRANSCRIPTIONAL STATE, THE TRANSCRIPTIONAL STATE OF CANCER, AND THE INTEGRATION OF THE DIFFERENT SEQUENCING TECHNIQUES, RITINPUT